Centers for Disease Control and Prevention: Guidance on the use of expedited partner therapy in the treatment of gonorrhea. 20 16a. Available at: https:// www.cdc.gov/std/epclgc-guidance.htm. Accessed March 23, 2017
Centers for Disease Control and Prevention: Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas, 2014. HIV Surveillance Supplemental Report 21 (No. 4), 2016b. Available at: http://www.cdc.gov/hivllibrary/reports/ survedlance.l Accessed April 3, 2016
Centers for Disease Control and Prevention: Sexually Transmitted Disease Surveillance, 2015. Atlanta, U.S. Department of Healch and Human Services, 2016c
Centers for Disease Control and Prevention: HIV among pregnant women, infants, and children. 2017. Available at: hnps:/ /www.cdc.gov/hiv/group/ gender/pregnanwomen.l Accessed March 26, 201
Cooper ER, Charurat M, Mofenson L, et al: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Ddic Syndr 29:484,2002
Corey L, Wald A: Maternal and neonatal herpes simplex virus infections. N Engl J Med 361(14):1376, 2009
Corey L, Wald A, Patel R, et al: Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350:11,t2004
Coste J, Job-Spira N, Fernandez H: Risk factors for spontaneous abortion: a case-control study in France. Hum Reprod 6:1332, 1991
Cotch MF, Hillier SL, Gibbs RS, et al: Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 178(2):374, 1998
Czeizel E, Rockenbauer M: A population based case-control teratologic study of oral metronidazole treatment during pregnancy. BJOG 105:322, 1998 Delaney S, Gardella C, Saracino M, et al: Seroprevalence of herpes simplex virus type 1 and 2 among pregnant women, 1989-2010. JAMA 312(7):746,2014